Message From President
It gives me great pleasure to announce to you a new e-learning initiative from the MACB. The PEP connect is an online learning module that is designed to give easy access to educational material on important topics in laboratory medicine. This collaborative effort between the MACB and Siemens Healthineers is to drive educational initiatives during the COVID19 pandemic. The MACB has a 90-day trial subscription license which allows participants to follow selected modules and print certificates upon completion. Take this opportunity and try out the new normal to learning.
Raja Dr. Elina Binti Raja Aziddin
Malaysian Association of Clinical Biochemists
What is PEPconnect Virtual Learning Campaign?
MACB is collaborating with Siemens Healthineers to bring exclusive educational content to MACB members via PEPconnect in The New Normal. PEPconnect is the industry’s first personalized education and performance experience for healthcare professionals – designed to increase staff competency, efficiency, and productivity. During the 8 weeks programme, PEPconnect focuses on uplifting MACB members’ knowledge, skills, and abilities with access to individual and competency based activities, webinars and performance support, such as videos and jobs aids, on demand.
Virtual Training on PEPconnect
We are glad to inform you that our subscription license for PEPconnect has been given an extension of time until the end of November. Therefore, for those who still have not registered for PEPconnect, please feel free to register to take the online modules at your own pace.
Invitation has been sent to those who have participated in the survey previously. You may also watch the recorded training on how to manage the PEPconnect on our website.
For your information, modules do not have to be taken in one sitting, you can start/stop at any time and begin from where you have left off. After the module has completed, you are encouraged to go through the assessment process to obtain the passing score to get your e-certificates.